ArticleFrontiers in pharmacology2024

Identification of ALEKSIN as a novel multi-IRF inhibitor of IRF- and STAT-mediated transcription in vascular inflammation and atherosclerosis.

Aleksandra Antonczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.